PRPO - Precipio, Inc.

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Precipio launches quantitative BCR-ABL 2.0 panel for patients with chronic myeloid leukemia
• Precipio to sell 4.13M shares at $0.45 in direct offering, private placement
• Precipio says cash burn reduced by $1.5M annually from efficiency projects
• Precipio GAAP EPS of -$0.13 misses by $0.02, revenue of $2.82M beats by $0.02M
• Precipio granted 180 day extension by Nasdaq to regain compliance
• Precipio files for $50M mixed shelf offering
• Precipio to distribute HemeScreen through Fisher Healthcare channel
• Precipio stock slumps 17%, set to snap 3-day winning streak
• Precipio GAAP EPS of -$0.40, revenue of $8.85M
• Precipio CFO Carl Iberger to step down
• Precipio sees 25% growth in Q4 prelim revenues
• Precipio terminates its equity line with Lincoln Park
• Clearside Biomedical, Eloxx Pharmaceuticals leads healthcare gainers; PDS Biotechnology, Sage Therapeutics among major losers
• Precipio shares surge on HemeScreen Anemia Panel launch
• Precipio EPS beats by $0.02, misses on revenue
• Precipio shares surge on launching hemescreen panel for Acute Myeloid Leukemia
• Precipio shares jump on launching its rapid COVID-19 antibody test on Amazon platform
• Precipio launches up to $20M ATM financing arrangement
• Precipio reports FY results
• Seeking Alpha Catalyst Watch